Evidence map›Paper›PMID 22745654›Full record

ArticlePloS one2012

Identification and validation of Ifit1 as an important innate immune bottleneck.

Jason E McDermott, Keri B Vartanian, Hugh Mitchell, Susan L Stevens, Antonio Sanfilippo, Mary P Stenzel-Poore

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. International journal of molecular sciences · 2023
    Article
  8. Article
  9. scDual-Seq ofFrontiers in immunology · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Sirtuin 1-Chromatin-Binding Dynamics Points to a Common Mechanism Regulating Inflammatory Targets in SIV Infection and in the Aging Brain.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2018
    Article
  15. Article
  16. Review
  17. Article
  18. World journal of gastroenterology · 2016
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jason E McDermottComputational Biology and Bioinformatics, Pacific Northwest National Laboratory, Richland, Washington, United States of America. Jason.McDermott@pnl.gov
Keri B Vartanian
Hugh Mitchell
Susan L Stevens
Antonio Sanfilippo
Mary P Stenzel-Poore
Oregon Health & Science University · USPacific Northwest National Laboratory · US

Funding

Molecular Mechanisms of LPS Preconditioning In StrokeR01NS050567 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI STENZEL-POORE, MARY P · 2005 to 2015
$3.3M
Ontology-driven Generation and Linking of Pathway Diagrams in Stroke PathobiologyR01NS057484 · NINDS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SANFILIPPO, ANTONIO P · 2007 to 2011
$1.9M
Toll-like Receptors: Novel targets of neuroprotection in ischemic brain injuryR01NS062381 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI STENZEL-POORE, MARY P · 2009 to 2013
$1.8M
NINDS NIH HHS R01 NS050567NINDS NIH HHS R01 NS057484NINDS NIH HHS R01NS057484-03NINDS NIH HHS R01 NS062381
6 · The paper itself

Abstract

The innate immune system plays important roles in a number of disparate processes. Foremost, innate immunity is a first responder to invasion by pathogens and triggers early defensive responses and recruits the adaptive immune system. The innate immune system also responds to endogenous damage signals that arise from tissue injury. Recently it has been found that innate immunity plays an important role in neuroprotection against ischemic stroke through the activation of the primary innate immune receptors, Toll-like receptors (TLRs). Using several large-scale transcriptomic data sets from mouse and mouse macrophage studies we identified targets predicted to be important in controlling innate immune processes initiated by TLR activation. Targets were identified as genes with high betweenness centrality, so-called bottlenecks, in networks inferred from statistical associations between gene expression patterns. A small set of putative bottlenecks were identified in each of the data sets investigated including interferon-stimulated genes (Ifit1, Ifi47, Tgtp and Oasl2) as well as genes uncharacterized in immune responses (Axud1 and Ppp1r15a). We further validated one of these targets, Ifit1, in mouse macrophages by showing that silencing it suppresses induction of predicted downstream genes by lipopolysaccharide (LPS)-mediated TLR4 activation through an unknown direct or indirect mechanism. Our study demonstrates the utility of network analysis for identification of interesting targets related to innate immune function, and highlights that Ifit1 can exert a positive regulatory effect on downstream genes.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCarrier ProteinsCell LineImmunity, InnateLipopolysaccharidesMacrophagesMiceReverse Transcriptase Polymerase Chain ReactionRNA-Binding ProteinsToll-Like ReceptorsAdaptor Proteins, Signal TransducingCarrier ProteinsIfit1 protein, mouseLipopolysaccharidesRNA-Binding ProteinsToll-Like Receptors

Identifiers

PMID22745654
PMCPMC3380000
OpenAlexW1973530869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.